Global Anti-Obesity Drugs Market Professional Survey Report 2016

Published: May, 2016 | Pages: 148 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

This report
Mainly covers the following product types
    Peripheral acting anti-obesity drugs
    Centrally acting anti-obesity drugs
The segment applications including
    Hospital use
    Clinic use
    Household
Segment regions including (the separated region report can also be offered)
    USA
    China
    UK
    France
    Switzerland
    Japan
    Germany
    India
The players list (Partly, Players you are interested in can also be added)
    Arena Pharmaceuticals
    F. Hoffmann-La Roche
    GlaxoSmithKline
    Orexigen Therapeutics
    Vivus
    Rhythm Pharmaceuticals
    Zafgen Inc
    Novo Nordisk
    Lunan Pharmaceutical Group?
    Takeda Pharmaceutical
    RocheAG
    KNOLL
    Nanjing Medical
    Nanjing Changao
    Hainan Sanyo Delin
    Chongqin Kangershou
    Guangdong Apollo
    Taiji Group
With no less than 15 top producers.

Data including (both global and regions): Market Size (both volume - Box and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Box, Cost, Gross margin etc.

More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!

 Table of Contents


1 Industry Overview of Anti-Obesity Drugs
    1.1 Definition and Specifications of Anti-Obesity Drugs
        1.1.1 Definition of Anti-Obesity Drugs
        1.1.2 Specifications of Anti-Obesity Drugs
    1.2 Classification of Anti-Obesity Drugs
        1.2.1 Peripheral acting anti-obesity drugs
        1.2.2 Centrally acting anti-obesity drugs
    1.3 Applications of Anti-Obesity Drugs
        1.3.1 Hospital use
        1.3.2 Clinic use
        1.3.3 Household
    1.4 Industry Chain Structure of Anti-Obesity Drugs
    1.5 Industry Overview and Major Regions Status of Anti-Obesity Drugs
        1.5.1 Industry Overview of Anti-Obesity Drugs
        1.5.2 Global Major Regions Status of Anti-Obesity Drugs
    1.6 Industry Policy Analysis of Anti-Obesity Drugs
    1.7 Industry News Analysis of Anti-Obesity Drugs

2 Manufacturing Cost Structure Analysis of Anti-Obesity Drugs
    2.1 Raw Material Suppliers and Price Analysis of Anti-Obesity Drugs
    2.2 Equipment Suppliers and Price Analysis of Anti-Obesity Drugs
    2.3 Labor Cost Analysis of Anti-Obesity Drugs
    2.4 Other Costs Analysis of Anti-Obesity Drugs
    2.5 Manufacturing Cost Structure Analysis of Anti-Obesity Drugs
    2.6 Manufacturing Process Analysis of Anti-Obesity Drugs

3 Technical Data and Manufacturing Plants Analysis of Anti-Obesity Drugs
    3.1 Capacity and Commercial Production Date of Global Anti-Obesity Drugs Major Manufacturers in 2015
    3.2 Manufacturing Plants Distribution of Global Anti-Obesity Drugs Major Manufacturers in 2015
    3.3 R&D Status and Technology Source of Global Anti-Obesity Drugs Major Manufacturers in 2015
    3.4 Raw Materials Sources Analysis of Global Anti-Obesity Drugs Major Manufacturers in 2015

4 Global Anti-Obesity Drugs Overall Market Overview
    4.1 2011-2016E Overall Market Analysis
        4.2.1 2011-2015 Global Anti-Obesity Drugs Capacity and Growth Rate Analysis
        4.2.2 2015 Anti-Obesity Drugs Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2011-2015 Global Anti-Obesity Drugs Sales and Growth Rate Analysis
        4.3.2 2015 Anti-Obesity Drugs Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2011-2015 Global Anti-Obesity Drugs Sales Price
        4.4.2 2015 Anti-Obesity Drugs Sales Price Analysis (Company Segment)
    4.5 Gross Margin Analysis
        4.5.1 2011-2015 Global Anti-Obesity Drugs Gross Margin
        4.5.2 2015 Anti-Obesity Drugs Gross Margin Analysis (Company Segment)

5 Anti-Obesity Drugs Regional Market Analysis
    5.1 USA Anti-Obesity Drugs Market Analysis
        5.1.1  USA Anti-Obesity Drugs  Market Overview
        5.1.2  USA 2011-2016E Anti-Obesity Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.1.3  USA 2011-2016E Anti-Obesity Drugs Sales Price Analysis
        5.1.4  USA 2015 Anti-Obesity Drugs Market Share Analysis
    5.2 China Anti-Obesity Drugs Market Analysis
        5.2.1  China Anti-Obesity Drugs  Market Overview
        5.2.2  China 2011-2016E Anti-Obesity Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.2.3  China 2011-2016E Anti-Obesity Drugs Sales Price Analysis
        5.2.4  China 2015 Anti-Obesity Drugs Market Share Analysis
    5.3 UK Anti-Obesity Drugs Market Analysis
        5.3.1  UK Anti-Obesity Drugs  Market Overview
        5.3.2  UK 2011-2016E Anti-Obesity Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.3.3  UK 2011-2016E Anti-Obesity Drugs Sales Price Analysis
        5.3.4  UK 2015 Anti-Obesity Drugs Market Share Analysis
    5.4 France Anti-Obesity Drugs Market Analysis
        5.4.1  France Anti-Obesity Drugs  Market Overview
        5.4.2  France 2011-2016E Anti-Obesity Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.4.3  France 2011-2016E Anti-Obesity Drugs Sales Price Analysis
        5.4.4  France 2015 Anti-Obesity Drugs Market Share Analysis
    5.5 Switzerland Anti-Obesity Drugs Market Analysis
        5.5.1  Switzerland Anti-Obesity Drugs  Market Overview
        5.5.2  Switzerland 2011-2016E Anti-Obesity Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.5.3  Switzerland 2011-2016E Anti-Obesity Drugs Sales Price Analysis
        5.5.4  Switzerland 2015 Anti-Obesity Drugs Market Share Analysis
    5.6 Japan Anti-Obesity Drugs Market Analysis
        5.6.1  Japan Anti-Obesity Drugs  Market Overview
        5.6.2  Japan 2011-2016E Anti-Obesity Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.6.3  Japan 2011-2016E Anti-Obesity Drugs Sales Price Analysis
        5.6.4  Japan 2015 Anti-Obesity Drugs Market Share Analysis
    5.7 Germany Anti-Obesity Drugs Market Analysis
        5.7.1  Germany Anti-Obesity Drugs  Market Overview
        5.7.2  Germany 2011-2016E Anti-Obesity Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.7.3  Germany 2011-2016E Anti-Obesity Drugs Sales Price Analysis
        5.7.4  Germany 2015 Anti-Obesity Drugs Market Share Analysis
    5.8 India Anti-Obesity Drugs Market Analysis
        5.8.1  India Anti-Obesity Drugs  Market Overview
        5.8.2  India 2011-2016E Anti-Obesity Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.8.3  India 2011-2016E Anti-Obesity Drugs Sales Price Analysis
        5.8.4  India 2015 Anti-Obesity Drugs Market Share Analysis

6 Global 2011-2016E Anti-Obesity Drugs Segment Market Analysis (by Type)
    6.1 Global 2011-2016E Anti-Obesity Drugs Sales by Type
    6.2 Different Types Anti-Obesity Drugs Product Interview Price Analysis
    6.3 Different Types Anti-Obesity Drugs Product Driving Factors Analysis
        6.3.1 Peripheral acting anti-obesity drugs Anti-Obesity Drugs Growth Driving Factor Analysis
        6.3.2 Centrally acting anti-obesity drugs Anti-Obesity Drugs Growth Driving Factor Analysis

7 Global 2011-2016E Anti-Obesity Drugs Segment Market Analysis (by Application)
    7.1 Global 2011-2016E  Consumption by Application
    7.2 Different Application  Product Interview Price Analysis
    7.3 Different Application  Product Driving Factors Analysis
        7.3.1 Hospital use Anti-Obesity Drugs Growth Driving Factor Analysis
        7.3.2 Clinic use Anti-Obesity Drugs Growth Driving Factor Analysis
        7.3.3 Household Anti-Obesity Drugs Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Anti-Obesity Drugs
    8.1 Arena Pharmaceuticals
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
        8.1.3 Arena Pharmaceuticals 2015 Anti-Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Arena Pharmaceuticals 2015 Anti-Obesity Drugs Business Region Distribution Analysis
    8.2 F. Hoffmann-La Roche
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
        8.2.3 F. Hoffmann-La Roche 2015 Anti-Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 F. Hoffmann-La Roche 2015 Anti-Obesity Drugs Business Region Distribution Analysis
    8.3 GlaxoSmithKline
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
        8.3.3 GlaxoSmithKline 2015 Anti-Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 GlaxoSmithKline 2015 Anti-Obesity Drugs Business Region Distribution Analysis
    8.4 Orexigen Therapeutics
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
        8.4.3 Orexigen Therapeutics 2015 Anti-Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Orexigen Therapeutics 2015 Anti-Obesity Drugs Business Region Distribution Analysis
    8.5 Vivus
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
        8.5.3 Vivus 2015 Anti-Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Vivus 2015 Anti-Obesity Drugs Business Region Distribution Analysis
    8.6 Rhythm Pharmaceuticals
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
        8.6.3 Rhythm Pharmaceuticals 2015 Anti-Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Rhythm Pharmaceuticals 2015 Anti-Obesity Drugs Business Region Distribution Analysis
    8.7 Zafgen Inc
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
        8.7.3 Zafgen Inc 2015 Anti-Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Zafgen Inc 2015 Anti-Obesity Drugs Business Region Distribution Analysis
    8.8 Novo Nordisk
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
        8.8.3 Novo Nordisk 2015 Anti-Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Novo Nordisk 2015 Anti-Obesity Drugs Business Region Distribution Analysis
    8.9 Lunan Pharmaceutical Group?
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
        8.9.3 Lunan Pharmaceutical Group? 2015 Anti-Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Lunan Pharmaceutical Group? 2015 Anti-Obesity Drugs Business Region Distribution Analysis
    8.10 Takeda Pharmaceutical
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
        8.10.3 Takeda Pharmaceutical 2015 Anti-Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Takeda Pharmaceutical 2015 Anti-Obesity Drugs Business Region Distribution Analysis
    8.11 RocheAG
        8.11.1 Company Profile
        8.11.2 Product Picture and Specifications
        8.11.3 RocheAG 2015 Anti-Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.11.4 RocheAG 2015 Anti-Obesity Drugs Business Region Distribution Analysis
    8.12 KNOLL
        8.12.1 Company Profile
        8.12.2 Product Picture and Specifications
        8.12.3 KNOLL 2015 Anti-Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.12.4 KNOLL 2015 Anti-Obesity Drugs Business Region Distribution Analysis
    8.13 Nanjing Medical
        8.13.1 Company Profile
        8.13.2 Product Picture and Specifications
        8.13.3 Nanjing Medical 2015 Anti-Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.13.4 Nanjing Medical 2015 Anti-Obesity Drugs Business Region Distribution Analysis
    8.14 Nanjing Changao
        8.14.1 Company Profile
        8.14.2 Product Picture and Specifications
        8.14.3 Nanjing Changao 2015 Anti-Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.14.4 Nanjing Changao 2015 Anti-Obesity Drugs Business Region Distribution Analysis
    8.15 Hainan Sanyo Delin
        8.15.1 Company Profile
        8.15.2 Product Picture and Specifications
        8.15.3 Hainan Sanyo Delin 2015 Anti-Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.15.4 Hainan Sanyo Delin 2015 Anti-Obesity Drugs Business Region Distribution Analysis
    8.16 Chongqin Kangershou
        8.16.1 Company Profile
        8.16.2 Product Picture and Specifications
        8.16.3 Chongqin Kangershou 2015 Anti-Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.16.4 Chongqin Kangershou 2015 Anti-Obesity Drugs Business Region Distribution Analysis
    8.17 Guangdong Apollo
        8.17.1 Company Profile
        8.17.2 Product Picture and Specifications
        8.17.3 Guangdong Apollo 2015 Anti-Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.17.4 Guangdong Apollo 2015 Anti-Obesity Drugs Business Region Distribution Analysis
    8.18 Taiji Group
        8.18.1 Company Profile
        8.18.2 Product Picture and Specifications
        8.18.3 Taiji Group 2015 Anti-Obesity Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.18.4 Taiji Group 2015 Anti-Obesity Drugs Business Region Distribution Analysis

9 Development Trend of Analysis of  Market
    9.1 Global  Market Trend Analysis
        9.1.1 Global 2016-2021  Market Size (Volume and Value) Forecast
        9.1.2 Global 2016-2021  Sales Price Forecast
        9.1.3 Global 2016-2021  Gross Margin Forecast
    9.2  Regional Market Trend
        9.2.1 USA 2016-2021 Anti-Obesity Drugs Consumption Forecast
        9.2.2 China 2016-2021 Anti-Obesity Drugs Consumption Forecast
        9.2.3 UK 2016-2021 Anti-Obesity Drugs Consumption Forecast
        9.2.4 France 2016-2021 Anti-Obesity Drugs Consumption Forecast
        9.2.5 Switzerland 2016-2021 Anti-Obesity Drugs Consumption Forecast
        9.2.6 Japan 2016-2021 Anti-Obesity Drugs Consumption Forecast
        9.2.7 Germany 2016-2021 Anti-Obesity Drugs Consumption Forecast
        9.2.8 India 2016-2021 Anti-Obesity Drugs Consumption Forecast
    9.3  Market Trend (Product type)
    9.4  Market Trend (Application)

10 Anti-Obesity Drugs Marketing Model Analysis
    10.1 Anti-Obesity Drugs Regional Marketing Model Analysis
    10.2 Anti-Obesity Drugs International Trade Model Analysis
    10.3 Traders or Distributors with Contact Information of Anti-Obesity Drugs by Regions
    10.4 Anti-Obesity Drugs Supply Chain Analysis

11 Consumers Analysis of Anti-Obesity Drugs
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis
    �

12 New Project Investment Feasibility Analysis of Anti-Obesity Drugs
    12.1 New Project SWOT Analysis of Anti-Obesity Drugs
    12.2 New Project Investment Feasibility Analysis of Anti-Obesity Drugs

13 Conclusion of the Global Anti-Obesity Drugs Market Professional Survey Report 2016

To request a free sample copy of this report, please complete the form below.

Interested in this report? Get your FREE sample now! Get a Free Sample

Did you know?

Our library has over 100000 reports on 1000s of topics

Over 100+ Fortune 500 companies rely on us

90,000+ people come to us for insights every month

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.